Adipotide 10 mg

Dragon Pharma Adipotide

For athletes, bodybuilders, and fitness enthusiasts focused on body composition optimization, understanding the mechanisms of adipose tissue regulation is essential. Adipotide (also known as FTPP or Prohibitin-Targeting Peptide) is a novel proapoptotic peptide that targets the blood vessels supplying adipose tissue. By selectively inducing apoptosis (programmed cell death) in the vascular endothelial cells of fat tissue, Adipotide causes targeted regression of adipose tissue. This Dragon Pharma Adipotide 10mg offering delivers high-purity lyophilized powder in a sterile 2mL vial, providing researchers with a premium compound for advanced metabolic and body composition research.

Adipotide functions through a unique mechanism targeting prohibitin, a protein expressed on the surface of endothelial cells that supply blood to adipose tissue. The peptide binds to these cells and triggers apoptosis, leading to the selective destruction of the vasculature feeding fat tissue. Research published in the NIH PubMed database demonstrates that Adipotide produces significant and sustained reductions in body fat in research models, with preferential targeting of white adipose tissue. This mechanism is distinct from traditional appetite suppressants or metabolic stimulants, offering a unique approach to studying adipose tissue biology and obesity-related conditions.

The relevance of Adipotide to the athletic and bodybuilding community is significant. For athletes seeking to achieve very low body fat levels for competition, understanding adipose tissue biology is crucial. Adipotide's targeted mechanism offers a unique research tool for studying fat reduction independent of caloric restriction or increased energy expenditure. Unlike compounds that work systemically, Adipotide's vascular targeting approach allows researchers to investigate adipose tissue reduction at the cellular level. This makes it valuable for research into stubborn fat deposits, body composition optimization, and the biology of adipose tissue.

Quality assurance is paramount in peptide research. While lab test results are pending for this specific batch, Dragon Pharma maintains rigorous quality control standards across all products. Each batch undergoes third-party HPLC-MS testing to verify purity and dosage. Lab test documentation will be available shortly, reflecting the company's commitment to transparency and quality.

For bodybuilders and strength athletes researching advanced body composition strategies, Adipotide offers a unique mechanism for studying adipose tissue reduction. Its targeted approach to fat tissue vasculature represents a distinct pathway from traditional metabolic compounds. Whether investigating strategies for adipose tissue reduction, body composition optimization, or metabolic health, Dragon Pharma's Adipotide delivers the purity, potency, and reliability required for serious research into adipose biology.

Note: This product is intended for laboratory research and scientific investigation purposes only. Not for human consumption or veterinary use.

Product Specifications

Usage Guidelines

Adipotide is supplied as a sterile lyophilized powder and must be reconstituted with bacteriostatic water prior to research use. For optimal stability, gently swirl the vial after adding the diluent—do not shake vigorously. Standard research protocols involve reconstituting the 10mg peptide with 2-4mL of bacteriostatic water, yielding a concentration of 2.5-5mg/mL. Typical research dosing in preclinical studies ranges from 0.5-2mg per administration, often administered daily or every other day via subcutaneous injection. Due to its unique mechanism targeting adipose vasculature, dosing protocols vary based on research objectives. It is recommended to store the reconstituted peptide in a refrigerator (2-8°C) and use within 28 days to maintain peptide integrity.

For researchers investigating comprehensive body composition and metabolic protocols, combining Adipotide with complementary compounds can yield synergistic insights. Consider exploring the following Dragon Pharma products to enhance your research:

• AOD 9604: A lipolytic peptide fragment studied for its complementary effects on fat metabolism.
• Survodutide: A dual GLP-1/glucagon agonist for comparative research on energy expenditure mechanisms.
• L-Carnitine 500mg: Studied for its role in fatty acid oxidation during metabolic research protocols.

Third-Party Lab Results

Shipping & Authenticity

• From USA Domestic warehouse: 2-5 business days.
• From International warehouse: 14-21 business days.
• Free and automatic re-shipping policy if package doesn't reach destination within 30 days.
• Original product directly from manufacturer.
• We accept credit cards and cryptocurrency—crypto payments receive an additional 20% discount at checkout.

Storage Instructions

To maintain maximum stability and potency of the lyophilized powder, store the unopened vial in a freezer at -20°C (-4°F) away from light. Upon reconstitution with bacteriostatic water, the solution must be stored in a refrigerator at 2-8°C (36-46°F) and should be used within 28 days. Avoid repeated freeze-thaw cycles as this may degrade the peptide structure.

Frequently Asked Questions